Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons dr. Y. van Sleen

Publicaties

Activation phenotypes defined by the coordinated expression of activation markers discriminate TCR-mediated and bystander T cell responses

COVID-19 boosters restore virus-specific immune responses in kidney transplant recipients unresponsive to primary vaccination

Overlapping macrophage immune profiles in polymyalgia rheumatica and giant cell arteritis

Understanding the complex immune system

Distinct landscapes of fibroblast subtypes in arteries of patients with giant cell arteritis

GM-CSF drives IL-6 production by macrophages in polymyalgia rheumatica

IL-2 mediates human bystander CD8+ T-cell responses to innate immune signals

Pre-Vaccination Immunotypes and Immune Entropy Are Indicators of Multiple Vaccine Responsiveness

Altered plasma levels and tissue expression of fibroblast activation protein alpha in giant cell arteritis

Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls

Pers/media

How Does COVID-19 Booster Affect Patients With GCA and Low Primary Vaccine Response?

Biomarkers may improve giant cell arteritis diagnosis

Vasculitis Foundation: international research insights

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijn

Meer informatie over de Sustainable Development Goals.